The Future of Platelet Concentrates in Sports Medicine: Platelet-Rich Plasma, Platelet-Rich Fibrin, and the Impact of Scaffolds and Cells on the Long-term Delivery of Growth Factors

Operative Techniques in Sports Medicine

Volumn 19, Issue 3, 2011, Pages 190-197

  Zumstein, Matthias A ^a   Bielecki, Tomasz ^b   Dohan Ehrenfest, David M ^c  

^a UNIVERSITY OF BERN   (Switzerland)

^b MEDICAL UNIVERSITY OF SILESIA   (Poland)

^c Chonnam National University   (South Korea)

Author keywords

Blood platelet; Fibrin; Growth factors; Leukocytes; Regenerative medicine; Sports medicine

Indexed keywords

BIOMATERIAL; FIBRIN; FIBRIN GLUE; GROWTH FACTOR; THROMBOCYTE CONCENTRATE;

ANTERIOR CRUCIATE LIGAMENT INJURY; ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION; ARTICLE; HUMAN; LEUKOCYTE; MUSCULOSKELETAL INJURY; ORTHOPEDIC SURGERY; PATELLA TENDON; PRIORITY JOURNAL; QUADRICEPS TENDON; ROTATOR CUFF RUPTURE; SPORTS MEDICINE; TENDINITIS; THROMBOCYTE RICH PLASMA;

EID: 79958106521     PISSN: 10601872     EISSN: 15579794     Source Type: Journal    
DOI: 10.1053/j.otsm.2011.01.001     Document Type: Article

References (63)

1. Dohan Ehrenfest D.M., Rasmusson L., Albrektsson T. Classification of platelet concentrates: From pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin. LPRF). Trends Biotechnol 2009, 27:158-167.
2. Mishra A., Woodall J., Vieira A. Treatment of tendon and muscle using platelet-rich plasma. Clin Sports Med 2009, 28:113-125.
3. Marx R.E., Carlson E.R., Eichstaedt R.M., et al. Platelet-rich plasma: Growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998, 85:638-646.
4. Whitman D.H., Berry R.L., Green D.M. Platelet gel: An autologous alternative to fibrin glue with applications in oral and maxillofacial surgery. J Oral Maxillofac Surg 1997, 55:1294-1299.
5. Weibrich G., Kleis W.K., Buch R., et al. The Harvest Smart PRePTM system versus the Friadent-Schütze platelet-rich plasma kit. Clin Oral Implants Res 2003, 14:233-239.
6. Weibrich G., Kleis W.K., Hafner G. Growth factor levels in the platelet-rich plasma produced by 2 different methods: Curasan-type PRP kit versus PCCS PRP system. Int J Oral Maxillofac Implants 2002, 17:184-190.
7. Weibrich G., Kleis W.K., Hafner G., et al. Growth factor levels in platelet-rich plasma and correlations with donor age, sex, and platelet count. J Craniomaxillofac Surg 2002, 30:97-102.
8. Fernandez-Barbero J.E., Galindo-Moreno P., et al. Flow cytometric and morphological characterization of platelet-rich plasma gel. Clin Oral Implants Res 2006, 17:687-693.
9. Dohan Ehrenfest D.M., Del Corso M., Diss A., et al. Three-dimensional architecture and cell composition of a Choukroun's platelet-rich fibrin clot and membrane. J Periodontol 2010, 81:546-555.
10. Matras H. Die Wirkungen verschiedener Fibrinpraparate auf Kontinuitat-strennungen der Rattenhaut. Osterr Z Stomatol 1970, 67:338-359.
11. Matras H. The use of fibrin sealant in oral and maxillofacial surgery. J Oral Maxillofac Surg 1982, 40:617-622.
12. Clark R.A. Fibrin and wound healing. Ann N Y Acad Sci 2001, 936:355-367.
13. Gibble J.W., Ness P.M. Fibrin glue: The perfect operative sealant?. Transfusion 1990, 30:741-747.
14. Rosenthal A.R., Harbury C., Egbert P.R., et al. Use of a platelet-fibrinogen-thrombin mixture as a corneal adhesive: Experiments with sutureless lamellar keratoplasty in the rabbit. Invest Ophthalmol 1975, 14:872-875.
15. Rosenthal A.R., Egbert P.R., Harbury C., et al. Use of platelet-fibrinogen-thrombin mixture to seal experimental penetrating corneal wounds. Albrecht Graefes Arch Klin Exp Ophthalmol 1978, 207:111-115.
16. Pearl R.M., Wustrack K.O., Harbury C., et al. Microvascular anastomosis using a blood product sealant-adhesive. Surg Gynecol Obstet 1977, 144:227-231.
17. Silverberg G.D., Harbury C.B., Rubenstein E. A physiological sealant for cerebrospinal fluid leaks. J Neurosurg 1977, 46:215-219.
18. Knighton D.R., Ciresi K.F., Fiegel V.D., et al. Classification and treatment of chronic nonhealing wounds. Successful treatment with autologous platelet-derived wound healing factors (PDWHF). Ann Surg 1986, 204:322-330.
19. Knighton D.R., Ciresi K., Fiegel V.D., et al. Stimulation of repair in chronic, nonhealing, cutaneous ulcers using platelet-derived wound healing formula. Surg Gynecol Obstet 1990, 170:56-60.
20. Knighton D.R., Doucette M., Fiegel V.D., et al. The use of platelet derived wound healing formula in human clinical trials. Prog Clin Biol Res 1988, 266:319-329.
21. Anitua E., Sanchez M., Orive G., et al. The potential impact of the preparation rich in growth factors (PRGF) in different medical fields. Biomaterials 2007, 28:4551-4560.
22. Dohan D.M., Choukroun J., Diss A., et al. Platelet-rich fibrin (PRF): A second-generation platelet concentrate. Part III: Leucocyte activation: A new feature for platelet concentrates?. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006, 101:e51-e55.
23. Bielecki T., Gazdzik T.S., Szczepanski T. Re: "The effects of local platelet rich plasma delivery on diabetic fracture healing.". What do we use: Platelet-rich plasma or platelet-rich gel?. Bone 2006, 39:1388.
24. Everts P.A., van Zundert A., Schonberger J.P., et al. What do we use: Platelet-rich plasma or platelet-leukocyte gel?. J Biomed Mater Res A 2008, 85:1135-1136.
25. Martin P., Leibovich S.J. Inflammatory cells during wound repair: The good, the bad and the ugly. Trends Cell Biol 2005, 15:599-607.
26. Dohan D.M., Choukroun J., Diss A., et al. Platelet-rich fibrin (PRF): A second-generation platelet concentrate. Part I: Technological concepts and evolution. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006, 101:e37-e44.
27. Dohan D.M., Choukroun J., Diss A., et al. Platelet-rich fibrin (PRF): A second-generation platelet concentrate. Part II: Platelet-related biologic features. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006, 101:e45-e50.
28. Everts P.A., Hoffmann J., Weibrich G., et al. Differences in platelet growth factor release and leucocyte kinetics during autologous platelet gel formation. Transfus Med 2006, 16:363-368.
29. Dohan Ehrenfest D.M., de Peppo G.M., Doglioli P., et al. Slow release of growth factors and thrombospondin-1 in Choukroun's platelet-rich fibrin (PRF): A gold standard to achieve for all surgical platelet concentrates technologies. Growth Factors 2009, 27:63-69.
30. Dohan Ehrenfest D.M. How to optimize the preparation of leukocyte- and platelet-rich fibrin (L-PRF, Choukroun's technique) clots and membranes: Introducing the PRF Box. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010, 110:275-278.
31. Dohan Ehrenfest D.M., Diss A., Odin G., et al. In vitro effects of Choukroun's PRF (platelet-rich fibrin) on human gingival fibroblasts, dermal prekeratinocytes, preadipocytes, and maxillofacial osteoblasts in primary cultures. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009, 108:341-352.
32. Dohan Ehrenfest D.M., Doglioli P., de Peppo G.M., et al. Choukroun's platelet-rich fibrin (PRF) stimulates in vitro proliferation and differentiation of human oral bone mesenchymal stem cell in a dose-dependent way. Arch Oral Biol 2010, 55:185-194.
33. Cieslik-Bielecka A., Gazdzik T.S., Bielecki T.M., et al. Why the platelet-rich gel has antimicrobial activity?. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007, 103:303-305.
34. Bielecki T.M., Gazdzik T.S., Arendt J., et al. Antibacterial effect of autologous platelet gel enriched with growth factors and other active substances: An in vitro study. J Bone Joint Surg Br 2007, 89:417-420.
35. Moojen D.J., Everts P.A., Schure R.M., et al. Antimicrobial activity of platelet-leukocyte gel against Staphylococcus aureus. J Orthop Res 2008, 26:404-410.
36. Cieslik-Bielecka A., Bielecki T., Gazdzik T.S., et al. Autologous platelets and leukocytes can improve healing of infected high-energy soft tissue injury. Transfus Apher Sci 2009, 41:9-12.
37. Dohan Ehrenfest D.M., Bielecki T., Del Corso M., et al. Shedding light in the controversial terminology for platelet-rich products: Platelet-rich plasma (PRP), platelet-rich fibrin (PRF), platelet-leukocyte gel (PLG), preparation rich in growth factors (PRGF), classification and commercialism. J Biomed Mater Res A 2010, 95:1280-1282.
38. Mishra A., Pavelko T. Treatment of chronic elbow tendinosis with buffered platelet-rich plasma. Am J Sports Med 2006, 34:1774-1778.
39. Schnabel L.V., Mohammed H.O., Miller B.J., et al. Platelet rich plasma (PRP) enhances anabolic gene expression patterns in flexor digitorum superficialis tendons. J Orthop Res 2007, 25:230-240.
40. Everts P.A., Devilee R.J., Brown-Mahoney C., et al. Platelet gel and fibrin sealant reduce allogeneic blood transfusions in total knee arthroplasty. Acta Anaesthesiol Scand 2006, 50:593-599.
41. Man D., Plosker H., Winland-Brown J.E. The use of autologous platelet-rich plasma (platelet gel) and autologous platelet-poor plasma (fibrin glue) in cosmetic surgery. Plast Reconstr Surg 2001, 107:229-237.
42. Simonpieri A., Del Corso M., Sammartino G., et al. The relevance of Choukroun's platelet-rich fibrin and metronidazole during complex maxillary rehabilitations using bone allograft. Part I: A new grafting protocol. Implant Dent 2009, 18:102-111.
43. Simonpieri A., Del Corso M., Sammartino G., et al. The relevance of Choukroun's platelet-rich fibrin and metronidazole during complex maxillary rehabilitations using bone allograft. Part II: Implant surgery, prosthodontics, and survival. Implant Dent 2009, 18:220-229.
44. Mazor Z., Horowitz R.A., Del Corso M., et al. Sinus floor augmentation with simultaneous implant placement using Choukroun's platelet-rich fibrin as the sole grafting material: A radiologic and histologic study at 6 months. J Periodontol 2009, 80:2056-2064.
45. He L., Lin Y., Hu X., et al. A comparative study of platelet-rich fibrin (PRF) and platelet-rich plasma (PRP) on the effect of proliferation and differentiation of rat osteoblasts in vitro. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009, 108:707-713.
46. Dohan Ehrenfest D.M., Del Corso M., Inchingolo F., et al. Selecting a relevant in vitro cell model for testing and comparing the effects of a Choukroun's platelet-rich fibrin (PRF) membrane and a platelet-rich plasma (PRP) gel: Tricks and traps. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010, 110:409-411.
47. Charrier J.B., Monteil J.P., Albert S., et al. Relevance of Choukroun's platelet-rich fibrin (PRF) and SMAS flap in primary reconstruction after superficial or subtotal parotidectomy in patients with focal pleiomorphic adenoma: A new technique. Rev Laryngol Otol Rhinol (Bord) 2008, 129:313-318.
48. Del Corso M., Sammartino G., Dohan Ehrenfest D.M. Re: "Clinical evaluation of a modified coronally advanced flap alone or in combination with a platelet-rich fibrin membrane for the treatment of adjacent multiple gingival recessions: A 6-month study.". J Periodontol 2009, 80:1694-1697.
49. Braccini F., Dohan D.M. The relevance of Choukroun's platelet rich fibrin (PRF) during facial aesthetic lipostructure (Coleman's technique): Preliminary results. Rev Laryngol Otol Rhinol (Bord) 2007, 128:255-260.
50. Braccini F., Tardivet L., Dohan Ehrenfest D.M. The relevance of Choukroun's platelet-rich fibrin (PRF) during middle ear surgery: Preliminary results. Rev Laryngol Otol Rhinol (Bord) 2009, 130:175-180.
51. Anitua E. Plasma rich in growth factors: Preliminary results of use in the preparation of future sites for implants. Int J Oral Maxillofac Implants 1999, 14:529-535.
52. Weibrich G., Kleis W.K., Hitzler W.E., et al. Comparison of the platelet concentrate collection system with the plasma-rich-in-growth-factors kit to produce platelet-rich plasma: A technical report. Int J Oral Maxillofac Implants 2005, 20:118-123.
53. Sanchez M., Anitua E., Orive G., et al. Platelet-rich therapies in the treatment of orthopaedic sport injuries. Sports Med 2009, 39:345-354.
54. Anitua E., Orive G., Aguirre J.J., et al. Clinical outcome of immediately loaded dental implants bioactivated with plasma rich in growth factors: A 5-year retrospective study. J Periodontol 2008, 79:1168-1176.
55. Dohan Ehrenfest D.M., Coelho P.G., Kang B.S., et al. Classification of osseointegrated implant surfaces: Materials, chemistry and topography. Trends Biotechnol 2010, 28:198-206.
56. Anitua E., Aguirre J.J., Algorta J., et al. Effectiveness of autologous preparation rich in growth factors for the treatment of chronic cutaneous ulcers. J Biomed Mater Res B Appl Biomater 2008, 84:415-421.
57. Sanchez M., Anitua E., Azofra J., et al. Comparison of surgically repaired Achilles tendon tears using platelet-rich fibrin matrices. Am J Sports Med 2007, 35:245-251.
58. Kon E., Buda R., Filardo G., et al. Platelet-rich plasma: Intra-articular knee injections produced favorable results on degenerative cartilage lesions. Knee Surg Sports Traumatol Arthrosc 2010, 18:472-479.
59. de Vos R.J., Weir A., van Schie H.T., et al. Platelet-rich plasma injection for chronic Achilles tendinopathy: A randomized controlled trial. JAMA 2010, 303:144-149.
60. Silva A., Sampaio R. Anatomic ACL reconstruction: Does the platelet-rich plasma accelerate tendon healing?. Knee Surg Sports Traumatol Arthrosc 2009, 17:676-682.
61. Bielecki T., Gazdzik T.S., Szczepanski T. Benefit of percutaneous injection of autologous platelet-leukocyte-rich gel in patients with delayed union and nonunion. Eur Surg Res 2008, 40:289-296.
62. Everts P.A., Devilee R.J., Brown-Mahoney C., et al. Exogenous application of platelet-leukocyte gel during open subacromial decompression contributes to improved patient outcome. A prospective randomized double-blind study. Eur Surg Res 2008, 40:203-210.
63. Everts P.A., Devilee R.J., Oosterbos C.J., et al. Autologous platelet gel and fibrin sealant enhance the efficacy of total knee arthroplasty: Improved range of motion, decreased length of stay and a reduced incidence of arthrofibrosis. Knee Surg Sports Traumatol Arthrosc 2007, 15:888-894.